https://scholars.lib.ntu.edu.tw/handle/123456789/454791
標題: | Selective activation of SHP2 activity by cisplatin revealed by a novel chemical probe-based assay | 作者: | Kuo C.-C. Chu C.-Y. JING-JER LIN Lo L.-C. |
公開日期: | 2010 | 卷: | 391 | 期: | 1 | 起(迄)頁: | 230-234 | 來源出版物: | Biochemical and Biophysical Research Communications | 摘要: | Src homology-2 (SH2) domain-containing phosphatase 2 (SHP2) is known to participate in several different signaling pathways to mediate cell growth, survival, migration, and differentiation. However, due to the lack of proper analytical tools, it is unclear whether the phosphatase activity of SHP2 is activated in most studies. We have previously developed an activity-based probe LCL2 that formed covalent linkage with catalytically active protein tyrosine phosphatases (PTPs). Here, by combining LCL2 with a SHP2 specific antibody, we established an assay system that enables the direct monitoring of SHP2 activity upon cisplatin treatment of cancer cells. The protocol is advantageous over conventional colorimetric or in-gel PTP assays as it is specific and does not require the use of radioisotope reagents. Using this assay, we found SHP2 activity was selectively activated by cisplatin. Moreover, the activation of SHP2 appeared to be specific for cisplatin as other DNA damage agents failed to activate the activity. Although the role of SHP2 activation by cisplatin treatments is still unclear to us, our results provide the first direct evidence for the activation of SHP2 during cisplatin treatments. More importantly, the concept of using activity-based probe in conjunction with target-specific antibodies could be extended to other enzyme classes. ? 2009 Elsevier Inc. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-72949110368&doi=10.1016%2fj.bbrc.2009.11.037&partnerID=40&md5=1635561bf711fb01e8dd2fd3ea5edb27 https://scholars.lib.ntu.edu.tw/handle/123456789/454791 |
ISSN: | 0006-291X | DOI: | 10.1016/j.bbrc.2009.11.037 | SDG/關鍵字: | a 2385; azacitidine; cisplatin; e 1383; enzyme antibody; etoposide; f 6627; fluorouracil; LCL 2 protein; p 4394; protein tyrosine phosphatase; protein tyrosine phosphatase SHP 2; radioisotope; unclassified drug; article; cancer cell; cell assay; colorimetry; DNA damage; drug selectivity; gel; human; human cell; priority journal; protein determination; sensitivity and specificity; Antibodies; Antineoplastic Agents; Biological Assay; Biotin; Cell Line, Tumor; Cisplatin; Enzyme Activation; Humans; Molecular Probes; Neoplasms; Phosphoric Acid Esters; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatases |
顯示於: | 生物化學暨分子生物學科研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。